Printer Friendly

I-FLOW BEGINS SUPPLYING NEW SIDEKICK INFUSION PUMP TO THE CYSTIC FIBROSIS FOUNDATION

 I-FLOW BEGINS SUPPLYING NEW SIDEKICK INFUSION PUMP
 TO THE CYSTIC FIBROSIS FOUNDATION
 IRVINE, Calif., Sept. 14 /PRNewswire/ -- I-Flow Corporation (NASDAQ: IFLO), manufacturer and seller of innovative ambulatory infusion devices, announced today that it has begun shipments of its new SideKick antibiotic drug delivery system to the Cystic Fibrosis Foundation. The SideKick is a revolutionary new drug delivery system designed to reduce health care costs for delivering drugs intravenously in the home.
 "We are extremely pleased to be able to supply an organization of the quality and international stature of the Cystic Fibrosis Foundation with our new SideKick," said I-Flow President and CEO Donald M. Earhart. "Healthcare providers across the country are quickly realizing the economic benefits associated with using our high quality, patient- friendly yet reasonably priced drug delivery system. This is the fourth supply agreement we have signed with a major healthcare provider since July 30, 1992."
 The SideKick competes in the fast growing market for disposable pumps designed to deliver antibiotics in the home. This year, a total of more than six million disposable pumps are expected to be sold for this purpose with a market value exceeding $60 million.
 I-Flow Corporation designs, develops, manufactures and markets technically advanced ambulatory infusion systems uniquely well suited to the alternate care environment. Reliable, efficient and easy to use, I-Flow products offer users substantial opportunities to expand their therapy base, improve quality of care, and increase productivity. These advantages translate into improved revenues and profits for healthcare providers while reducing costs and improving the quality of life for patients.
 -0- 9/14/92
 /CONTACT: Jim Dal Porto of I-FLow, 714-553-0888/ CO: I-Flow Corporation; Cystic Fibrosis Foundation ST: California IN: HEA SU:


GK-MA -- NY008 -- 9041 09/14/92 10:30 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 14, 1992
Words:289
Previous Article:U.S. HEALTHCARE ANNOUNCES NEW JERSEY APPROVAL OF RATE INCREASE
Next Article:I-FLOW BEGINS SUPPLYING NEW SIDEKICK INFUSION PUMP TO THE CYSTIC FIBROSIS FOUNDATION
Topics:


Related Articles
Genesee's "Boo-ster" program earns smiles.
I-FLOW CORP. RECEIVES FDA PERMISSION TO MARKET ITS NEW DISPOSABLE DRUG DELIVERY SYSTEM
I-FLOW ACHIEVES SECOND QUARTER REVENUE GROWTH OF 50 PERCENT AND FIRST SHIPMENTS OF DISPOSABLE PUMPS
I-FLOW SIGNS NATIONAL PRICING AGREEMENT FOR NEW DISPOSABLE PUMP WITH OPTION CARE
I-FLOW SIGNS NATIONAL PRICING AGREEMENT FOR NEW DISPOSABLE PUMP WITH HOME INTENSIVE CARE
I-FLOW BEGINS SUPPLYING NEW SIDEKICK INFUSION PUMP TO THE CYSTIC FIBROSIS FOUNDATION
I-FLOW SIGNS THIRD NATIONAL PRICING AGREEMENT IN FOUR WEEKS FOR NEW DISPOSABLE PUMP
I-FLOW CORP. FILES FOR FDA PERMISSION TO MARKET NEW DRUG DELIVERY SYSTEM
MCNEIL PHARMACEUTICAL SIGNS ON AS GREAT STRIDES WALKATHON NATIONAL SPONSOR
Mpex Pharmaceuticals Announces IND Filing for Aerosol Candidate to Treat Respiratory Infections Associated With Cystic Fibrosis; Company is...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters